Telemetry Investments, L.L.C. Acorda Therapeutics Inc Transaction History

Telemetry Investments, L.L.C.

  • $63.3 Million
  • Q4 2022

A detailed history of Telemetry Investments, L.L.C. transactions in Acorda Therapeutics Inc stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 132,500 shares of ACOR stock, worth $34,450. This represents 0.16% of its overall portfolio holdings.

Number of Shares
132,500
Holding current value
$34,450
% of portfolio
0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.52 - $0.77 $68,900 - $102,025
132,500 New
132,500 $102,000

Others Institutions Holding ACOR

# of Institutions
1
Shares Held
133K
Call Options Held
0
Put Options Held
0
View Full List

About ACORDA THERAPEUTICS INC

ACOR Quotes by TradingView
  • Ticker ACOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 24,338,400
  • Market Cap $6.33M
  • Description
  • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...
More about ACOR
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email